Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125697002 | 12569700 | 2 | F | 201601 | 20160721 | 20160719 | 20160727 | EXP | CA-VIIV HEALTHCARE LIMITED-CA2016GSK102752 | VIIV | 60.00 | YR | M | Y | 0.00000 | 20160727 | PH | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125697002 | 12569700 | 1 | PS | TIVICAY | DOLUTEGRAVIR SODIUM | 1 | Oral | 50 MG, 1D | 204790 | 50 | MG | TABLET | QD | ||||||
| 125697002 | 12569700 | 2 | SS | 3TC | LAMIVUDINE | 1 | Oral | 300 MG, 1D | 0 | 300 | MG | TABLET | QD | ||||||
| 125697002 | 12569700 | 3 | SS | RETROVIR | ZIDOVUDINE | 1 | UNK | N | 0 | ||||||||||
| 125697002 | 12569700 | 4 | SS | RALTEGRAVIR. | RALTEGRAVIR | 1 | UNK | N | 0 | ||||||||||
| 125697002 | 12569700 | 5 | SS | ZIAGEN | ABACAVIR SULFATE | 1 | Oral | 600 MG, 1D | 0 | 600 | MG | TABLET | QD | ||||||
| 125697002 | 12569700 | 6 | SS | MYFORTIC | MYCOPHENOLATE SODIUM | 1 | N | 0 | |||||||||||
| 125697002 | 12569700 | 7 | C | TACROLIMUS. | TACROLIMUS | 1 | U | 0 | |||||||||||
| 125697002 | 12569700 | 8 | C | TMP-SMX | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | U | 0 | |||||||||||
| 125697002 | 12569700 | 9 | C | ALLOPURINOL. | ALLOPURINOL | 1 | U | 0 | |||||||||||
| 125697002 | 12569700 | 10 | C | PREDNISONE. | PREDNISONE | 1 | U | 0 | |||||||||||
| 125697002 | 12569700 | 11 | C | DEXLANSOPRAZOLE | DEXLANSOPRAZOLE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125697002 | 12569700 | 1 | HIV infection |
| 125697002 | 12569700 | 2 | HIV infection |
| 125697002 | 12569700 | 3 | Product used for unknown indication |
| 125697002 | 12569700 | 4 | HIV infection |
| 125697002 | 12569700 | 5 | HIV infection |
| 125697002 | 12569700 | 6 | Product used for unknown indication |
| 125697002 | 12569700 | 7 | Immunosuppressant drug therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125697002 | 12569700 | HO |
| 125697002 | 12569700 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125697002 | 12569700 | Anaemia | |
| 125697002 | 12569700 | Neutropenia | |
| 125697002 | 12569700 | Renal transplant |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125697002 | 12569700 | 1 | 201601 | 0 | ||
| 125697002 | 12569700 | 2 | 2007 | 0 | ||
| 125697002 | 12569700 | 3 | 201601 | 0 | ||
| 125697002 | 12569700 | 4 | 201601 | 201601 | 0 | |
| 125697002 | 12569700 | 5 | 2007 | 0 |